PUMA BIOTECHNOLOGY, INC. Quarterly Depreciation in USD from Q1 2019 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
Summary
Puma Biotechnology, Inc. quarterly/annual Depreciation history and growth rate from Q1 2019 to Q2 2024.
  • Puma Biotechnology, Inc. Depreciation for the quarter ending June 30, 2024 was $100K, unchanged year-over-year.
  • Puma Biotechnology, Inc. Depreciation for the twelve months ending June 30, 2024 was $400K, a 20% decline year-over-year.
  • Puma Biotechnology, Inc. annual Depreciation for 2023 was $400K, a 33.3% decline from 2022.
  • Puma Biotechnology, Inc. annual Depreciation for 2022 was $600K, a 14.3% decline from 2021.
  • Puma Biotechnology, Inc. annual Depreciation for 2021 was $700K, a 22.2% decline from 2020.
Depreciation, Trailing 12 Months (USD)
Depreciation, Quarterly (USD)
Depreciation, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 $400K $100K $0 0% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-01
Q1 2024 $400K $100K $0 0% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-02
Q4 2023 $400K $100K $0 0% Oct 1, 2023 Dec 31, 2023 10-K 2024-02-29
Q3 2023 $400K $100K -$100K -50% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-02
Q2 2023 $500K $100K $0 0% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-01
Q1 2023 $500K $100K -$100K -50% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-02
Q4 2022 $600K $100K $0 0% Oct 1, 2022 Dec 31, 2022 10-K 2024-02-29
Q3 2022 $600K $200K $0 0% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-02
Q2 2022 $600K $100K -$100K -50% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-03
Q1 2022 $700K $200K $0 0% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-04
Q4 2021 $700K $100K -$100K -50% Oct 1, 2021 Dec 31, 2021 10-K 2024-02-29
Q3 2021 $800K $200K $0 0% Jul 1, 2021 Sep 30, 2021 10-Q 2021-11-04
Q2 2021 $800K $200K -$100K -33.3% Apr 1, 2021 Jun 30, 2021 10-Q 2021-08-05
Q1 2021 $900K $200K $0 0% Jan 1, 2021 Mar 31, 2021 10-Q 2021-05-06
Q4 2020 $900K $200K Oct 1, 2020 Dec 31, 2020 10-K 2023-03-02
Q3 2020 $200K $0 0% Jul 1, 2020 Sep 30, 2020 10-Q 2020-11-05
Q2 2020 $300K Apr 1, 2020 Jun 30, 2020 10-Q 2020-08-06
Q1 2020 $200K $0 0% Jan 1, 2020 Mar 31, 2020 10-Q 2020-05-07
Q3 2019 $200K Jul 1, 2019 Sep 30, 2019 10-Q 2019-11-07
Q1 2019 $200K Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-07
* An asterisk sign (*) next to the value indicates that the value is likely invalid.